Stanley Erck, Novavax CEO (Andrew Harnik/AP Images)

No­vavax pulls out of Covid-19 vac­cine al­liance with Gavi

No­vavax is pulling out of its Covid-19 vac­cine deal with Gavi, the Vac­cine Al­liance, a glob­al part­ner­ship tasked with en­sur­ing vac­cine ac­cess in low­er-in­come coun­tries, fol­low­ing an al­leged con­tract vi­o­la­tion.

The Mary­land-based com­pa­ny claimed on Fri­day that Gavi failed to pur­chase at least 350 mil­lion dos­es of its pro­tein-based vac­cine Nu­vax­ovid by the end of the year, per an ad­vanced pur­chase agree­ment. Gavi, the World Health Or­ga­ni­za­tion and the Coali­tion for Epi­dem­ic Pre­pared­ness In­no­va­tions (CEPI) are co-lead­ers of CO­V­AX, an ef­fort to en­sure that all par­tic­i­pat­ing coun­tries, re­gard­less of in­come lev­els, have ac­cess to vac­cines.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.